The ADC Cytotoxic Payloads / Warheads market is anticipated to grow at a CAGR of 12.4% till 2030, claims Roots Analysis
With six approved drugs, namely POLIVY™, LUMOXITI™, BESPONSA ® , MYLOTARG™, KADCYLA ® , ADCETRIS® and over 300 drugs underdevelopment, antibody drug conjugates (ADCs) have emerged as a promising class of targeted therapies for various disease indications Roots Analysis has announced the addition of “ ADC Cytotoxic Payloads / Warheads: Products and Services Market, 2021-2030 ” report to its list of offerings. Given the fact that ADCs are highly potent cytotoxic molecules, the manufacturing of ADCs requires elaborate and advanced technical capabilities and highly potent chemical substances. Specifically, the multi-step process of production of cytotoxic payloads, which are complex structures used in ADCs, requires a specially designed and contained environment, dedicated manufacturing facilities, specialized analytical and purification techniques, and storage facilities. To order this 130+ page report, which features 50+ figures and 15+ tables, please visit